Condition: Colorectal Cancer · Sponsor: Kahr Bio Australia Pty Ltd
This clinical study is testing whether a new combination of medicines (DSP107 and atezolizumab) is more effective and safer than an existing treatment (fruquintinib) for people with advanced colorectal cancer that is microsatellite stable (MSS). Participants will be randomly assigned to receive one of the two treatments, and researchers will monitor how well the cancer responds, how safe the treatments are, and how the body processes them. The study hopes to show that the new combination can improve outcomes for patients with this type of colorectal cancer.
This description comes directly from the study's public registry record.
Adam Foley Comer · +972 54 749 1753 · adam@kahrbio.com
Always discuss trial participation with your own doctor first.
| University of Colorado Hospital- Anschutz Cancer Center Pavillion (ACP) | Aurora, Colorado, United States | Recruiting |
| University of Colorado Cancer Center - Highlands Ranch Hospital | Highlands Ranch, Colorado, United States | Recruiting |
| Mayo Clinic | Florida City, Florida, United States | Recruiting |
| Duke University Medical Center - Duke Cancer Center | Durham, North Carolina, United States | Recruiting |
| UPMC Hillman Cancer Center | Pittsburgh, Pennsylvania, United States | Recruiting |
| The University of Texas MD Anderson Cancer Center | Texas City, Texas, United States | Recruiting |
| The Queen Elizabeth Hospital | Woodville, Adelaide, Australia | Recruiting |
| Chris O'brien Lifehouse | Camperdown, New South Wales, Australia | Recruiting |
| Westmead Hospital | Westmead, New South Wales, Australia | Recruiting |
| Icon Cancer Centre | South Brisbane, Queensland, Australia | Recruiting |
| Flinders Medical Centre SA | Bedford Park, South Australia, Australia | Recruiting |
| Monash Health | Clayton, Victoria, Australia | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07235293